Dechra Pharmaceuticals Investor Relations Material
Latest events
H1 2023
Dechra Pharmaceuticals
H2 2023
12 Oct, 2023
Trading Update
22 May, 2023
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Dechra Pharmaceuticals plc
Access all reports
Dechra Pharmaceuticals plc is a global veterinary pharmaceuticals company specializing in the development, manufacture, and distribution of products for animal health. The company provides a broad range of pharmaceuticals, including treatments for companion animals and livestock, as well as veterinary-specific diet products. Its offerings cover therapeutic areas such as endocrinology, dermatology, pain management, and anti-infectives. The company is headquartered in Northwich, United Kingdom, and its shares are listed on the LSE (London Stock Exchange).
Latest articles
)
Verisure: Security Leader Ready for a Comeback IPO
Verisure, Europe's leading monitored alarm provider, is preparing a comeback IPO in 2025 that could be one of the year's most significant listings.
16 Sep 2025
)
Stephen J. Squeri: American Express Veteran Chairman and CEO
Stephen Squeri has spent over four decades at American Express, rising through the ranks to lead one of the world's most recognized brands.
15 Sep 2025
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
Ticker symbol
DPH
Country
🇬🇧 United Kingdom